Parkinson's Flashcards
What is Parkinson’s
Loss of dopamine neurons from substantia nigra in the basal ganglia (motor control region and key target of dopamine neurons)
Parkinson’s does not start at substantial nigra - may start in lower brain stem and olfactory bulb.
Parkinson’s px may experience loss of sense of smell and sleep disturbances before motor symptoms start
What is the prodromal phase of Parkinson’s
hyposmia, REM sleep behaviour disorder, excessvie daytime sleepiness, depression
Stable PD: non-motor fluctuations
What is the unstable phase of PD
increasing NMS burden, balance problems, drug effects wearing off
What is the advanced phase of PD
risk of pneumonia, increasing dependency. Motor: 2 hours off per day, 1 hour with troublesome dyskinesia. Levodopa over 5x a day. Dysphagia. Non-motor: mild dementia, neuropsychiatric, non-motor fluctuations, night time sleep dysfunction
What are the motor symptoms of PD
Shaking (while resting), rigidity on passive movements, bradykinesia, poverty of movement (hypokinesia), shuffling gait, freezing (feet glued to the ground)
Early PD: signs and symptoms unilateral
Progressive: bilateral
What are the on and off motor symptoms
Off: untreated, not enough dopamine, having motor symptoms
On: alleviation of symptoms on treatment
What is the Hoehn and Yahr Scale
Progression:
1 - Unilateral involvement with minimal or no functional disability
2 - bilateral or midline without impairment of balance
3 - bilateral disease: mild to moderate disability with impaired postural reflexes
4 - severely disabling disease; still able to walk to stand unassisted
5 - confined to bed
What is the clinical diagnosis of PD
bradykinesia + rigidity or 4-6 Hz resting tremor
How is olfactory testing done in PD
Olfactory dysfunction present in 70-100% of px.
Olfaction preserved in: PARK 2 (early onset genetic PD, PSP/CBD, vascular and drug induced parkinsonism, mild OD in SMA and Alzheimer’s Disease
What is DaTSCAN
DaTSCAN: SPECT imaging of membrane dopamine transporters. Detects degeneration of dopaminergic nigrostriatal pathway. Measures dopamine uptake in the basal ganglia.
Indictive but not diagnostic. Can show progressive loss of dopamine transporters
What are the non motor symptoms of PD
Neuropsychiatric (psychosis, depression, anxiety, apathy, dementia), drug induced (hallucination), sensory disorders (pain, RLS, olfaction), urinary disorders, fatigue, sexual dysfunction, sleep disorders, GI disorders (constipation), autonomic dysfunction
In prodromal stage: REM sleep disorder and loss of sense of smell
What is the first line treatment for PD
Levodopa is first line. However, it is metabolised greatly in the periphery before reaching the brain. Levodopa is given with DOPA decarboxylase inhibitor to prevent this. Excessive peripheral dopamine signalling also causes adverse side effects.
What COMT inhibitors are used
COMT inhibitors (entacapone, tolcapone, opicapone) can also be given for dual inhibition.
What dopamine agonists are used
Pramipexole, Ropinirole, Rotigotine patch) can be given to imitate the effects of dopamine
What MAO-B inhibitors are used
selegiline and rasagiline
What are the motor complications with levodopa
motor fluctuations -> on/off phenomena and wearing off, dyskinesia (involuntary movements)
What is the pulsatile delivery of levodopa
leads to pulsatile stimulation of dopamine receptors Dyskinesia can occur after over stimulation with levodopa
What are the non-oral ther
Ritigotine patch (transdermal, use for 24 hours for constant delivery, need to change site of application to prevent rashes), subcutaneous apomorphine infusion or APO-pen (dopamine agonist, 16 hours a day), duodenal carbidopa/levodopa gel infusion (PEG with duodenal tube, morning bolus dose, continuous maintenance infusion over 16 hours)
What genetic compo
encoding alpha synuclein; LRRK2; DJ-1; PINK1
What is the neuropathology of Parkinson’s
loss of pigmented cell bodies in the substantia nigra pars compacta. Marked by loss of neuromelanin (oxidation of dopamine) containing dopamine cells in mid -brain SNc
What are Lewy bodies
halo structures. Contains alpha-synuclein and ubiquitin (tags damaged proteins and transport to proteasome) clumps.
When do halo structures start to appear
when striatal DA reduced by 60-80%
What does 18F dopa do
show reduced number of DA nerve terminals, through dopamine transporters on the terminal of neurons.
How does mitchondrial dysfunction occur in PD
: complex 1 in respiratory chain not working properly. Leads to reduction in ATP generation and free radical generation. Increase in reactive oxygen species and therefore oxidative stress.
What does activated microglial do in PD
infiltration of microglia in the substantial nigra to release inflammatory markers